Warburg Pincus eyes acquisition of Maneesh Pharma unit for $215M. Deal highlights PE interest in India's growing...
pharma manufacturing
India's drug regulator increases scrutiny of GLP-1 weight loss drugs due to unauthorized sales and improper prescriptions....
India's DCGI intensifies crackdown on illegal sales & misleading ads of GLP-1 weight loss drugs. Aiming to...
India's drug regulator increases scrutiny on GLP-1 drugs to prevent misuse and illegal sales, ensuring patient safety...
Indian drugmakers launch affordable generic versions of Ozempic & Wegovy, slashing costs by 70%. Increased access to...
Lilly International President Patrick Johnson sees India as an attractive investment hub, citing faster clinical trial approvals...
Sun Pharma introduces Noveltreat & Sematrinity semaglutide in India, offering affordable alternatives for diabetes & weight management....
Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...
Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...
Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...